Back to DE D. E. Shaw & Co., Inc.

AXSMAXSM
25 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in AXSOME THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 604,753 shares of AXSM (AXSOME THERAPEUTICS INC), worth $148M as of 2026-Q2. The position was increased (+0.2% shares). AXSM represents 0.1% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$148M

Current Shares

604,753

Total Value Change

+$147.1M

Total Shares Change

+569,997

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
604,753
+0.2%
$148M0.1%$244.77
30
2026-Q1
Increased
603,465
+9.9%
$102M0.1%$164.05
33
2025-Q4
Increased
549,113
+85.3%
$100.3M0.1%$148.79
47
2025-Q3
Increased
296,287
+47.6%
$36M0.0%$117.62
40
2025-Q2
Decreased
200,764
-63.3%
$21M0.0%$103.36
0
2025-Q1
Increased
547,665
+2591.8%
$63.9M0.1%$118.53
48
2024-Q4
Increased
20,346
+601.6%
$1.7M0.0%$84.78
41
2024-Q3
Decreased
2,900
-54.2%
$260,6230.0%$89.64
0
2024-Q2
Decreased
6,334
-18.5%
$509,8870.0%$80.50
0
2024-Q1
Decreased
7,769
-15.4%
$619,9660.0%$79.80
0
2023-Q4
New
9,184
-
$730,9550.0%$79.59
34
2022-Q3
Exited
0
-100.0%
$00.0%$44.15
0
2022-Q2
Decreased
6,762
-95.7%
$259,0000.0%$36.49
0
2022-Q1
New
155,392
-
$6.4M0.0%$40.02
38
2021-Q4
Exited
0
-100.0%
$00.0%$38.02
0
2021-Q3
Decreased
13,939
-39.5%
$459,0000.0%$34.17
0
2021-Q2
Decreased
23,049
-30.6%
$1.6M0.0%$69.66
0
2021-Q1
Decreased
33,218
-80.1%
$1.9M0.0%$55.91
0
2020-Q4
Decreased
167,182
-27.7%
$13.6M0.0%$83.26
0
2020-Q3
Decreased
231,242
-1.9%
$16.5M0.0%$72.28
0
2020-Q2
Decreased
235,703
-34.3%
$19.4M0.0%$76.36
0
2020-Q1
Increased
358,695
+329.8%
$21.1M0.0%$57.58
46
2019-Q4
Decreased
83,463
-30.4%
$8.6M0.0%$103.83
0
2019-Q3
Increased
119,951
+245.1%
$2.4M0.0%$22.09
42
2019-Q2
New
34,756
-
$895,0000.0%$25.75
34

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used